Regulating effect of Qifu Yin on intestinal microbiota in mice with memory impairment induced by scopolamine hydrobromide

被引:1
|
作者
Liu, Shiqi [2 ]
Zhang, Qingling [3 ]
Zhao, Fuxia [1 ]
Deng, Fanying [1 ]
Wang, Yan [1 ]
机构
[1] Shanxi Univ Chinese Med, Inst Pharmaceut & Food Engn, Jinzhong 030619, Shanxi, Peoples R China
[2] Heilongjiang Univ Chinese Med, Sch Basic Med, Harbin 150040, Heilongjiang, Peoples R China
[3] Heilongjiang Univ Chinese Med, Clin Med Coll 1, Harbin 150040, Heilongjiang, Peoples R China
关键词
Qifu yin (QFY); 16S rDNA; Memory impairment (MI); Behavioral experiments; Intestinal microbiota; DISEASE; CALCIUM;
D O I
10.1016/j.jep.2024.118445
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Qifu Yin (QFY) originates from "Jingyue Quanshu center dot Volume 51 center dot New Fang Bazhen center dot Buzhen" a work by Zhang Jingyue, a distinguished Chinese medical practitioner from the Ming Dynasty. QFY is composed of Ginseng Radix et Rhizoma, Rehmanniae Radix Praeparata, Angelicae Sinensis Radix, Atractylodis Macrocephalae Rhizoma, Glycyrrhizae Radix et Rhizoma Praeparata Cum Melle, Ziziphi Spinosae Semen, and Polygalae Radix. QFY is frequently employed to address memory loss and cognitive impairment stemming from vascular dementia, Alzheimer's disease (AD), and related conditions. Our findings indicate that QFY can mitigate nerve cell damage. Moreover, the study explores the impact of QFY on the calcium ion pathway and sphingolipid metabolism in mice with myocardial infarction, presenting a novel perspective on QFY's mechanism in ameliorating myocardial infarction through lipidomics. While this research provides an experimental foundation for the clinical application of QFY, a comprehensive and in-depth analysis of its improvement mechanism remains imperative. Aim of the study: To clarify the regulatory mechanism of QFY on intestinal microecology in mice with memory impairment (MI). Material and methods: The memory impairment mouse model was established by intraperitoneal injection of scopolamine hydrobromide. Kunming (KM) mice were randomly divided into blank group, Ginkgo tablet group (0.276 g/kg), QFY high, medium and low dose groups (17.2 g/kg, 8.6 g/kg, 4.3 g/kg). The effect on memory ability was evaluated by open field and step-down behavioral experiments. The morphological changes of nerve cells in the hippocampus of mice were observed by pathological method. The contents of superoxide dismutase (SOD), malondialdehyde (MDA), catalase (CAT) and glutathione peroxidase (GSH-Px) in the brain tissue of mice were detected. The expression levels of CREB, Brain-Derived Neurotrophic Factor (BDNF) and Recombinant Amyloid Precursor Protein (APP) in the hippocampus of mice were determined using immunohistochemistry. The expression of N-methyl-D-aspartate receptor (NMDAR) and cAMP response element binding protein (CREB) related factors in the serum of mice was analyzed by ELISA. The levels of apoptosis signal-regulating kinase-1 (ASK1) and c-Jun N-terminal kinase (JNK) mRNA in the hippocampus were detected by quantitative real-time fluorescence polymerase chain reaction (qPCR). The intestinal feces of mice were collected, and the 16 S rDNA technology was used to detect the changes in intestinal microbiota microecological structure of feces in each group. Results: Behavioral experiments showed that the high-dose QFY group exhibited a significant increase in exercise time (P<0.05) and a decrease in diagonal time (P<0.05) compared to the model group. The medium-dose group of QFY showed a reduction in diagonal time (P<0.05). Additionally, the latency time significantly increased in the medium and high-dose groups of QFY (P<0.01). The number of errors in the low, medium and high dose groups was significantly decreased (P<0.05, P<0.01, P<0.01). The nerve cells in the CA1 and CA3 regions of QFY-treated mice demonstrated close arrangement and clear structure. Furthermore, the content of SOD significantly increased (P<0.01) and the content of MDA significantly decreased (P<0.05) in the low and highdose QFY groups. The content of CAT in the medium-dose group significantly increased (P < 0.05). Immunohistochemical analysis showed a significant reduction in the number of APP expression particles in the CA1 and CA3 regions of all QFY groups. Moreover, BDNF expression significantly increased in the medium and high-dose groups, while CREB expression significantly increased in the low and medium-dose groups of QFY within the CA1 and CA3 regions. Serum analysis revealed significant increases in CREB content in the low, medium, and high dose groups of QFY (P<0.01, P<0.05, P<0.05), and decreases in NMDAR content across all QFY dose groups (P<0.01). PCR analysis showed a significant decrease in the contents of ASK1 and JNK in the medium-dose group (P<0.01). Microecological analysis of intestinal microbiota demonstrated a significant restoration trend in the relative abundance of Fusobacteria, Planctomycetes, and Verrucomicrobia (P<0.01 or P<0.05) at the phylum level in the QFY groups. At the genus level, Akkermansia, Paramuribaculum, Herminiimonas, Erysipelatoclostridium and other genera in the QFY groups showed a significant trend of relative abundance restoration (P<0.01 or P<0.05). Conclusion: QFY can improve the memory of MI animals induced by scopolamine hydrobromide by restoring the homeostasis of intestinal microbiota and regulating related indexes in serum and brain tissue.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Effect of rivastigmine on scopolamine-induced memory impairment in rats
    Bejar, C
    Wang, RH
    Weinstock, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 383 (03) : 231 - 240
  • [22] Flammulina velutipes polysaccharides improve scopolamine-induced learning and memory impairment in mice by modulating gut microbiota composition
    Su, Anxiang
    Yang, Wenjian
    Zhao, Liyan
    Pei, Fei
    Yuan, Biao
    Zhong, Lei
    Ma, Gaoxing
    Hu, Qiuhui
    FOOD & FUNCTION, 2018, 9 (03) : 1424 - 1432
  • [23] Fermented rice peptides attenuate scopolamine-induced memory impairment in mice by regulating neurotrophic signaling pathways in the hippocampus
    Corpuz, Henry M.
    Fujii, Hiroshi
    Nakamura, Soichiro
    Katayama, Shigeru
    BRAIN RESEARCH, 2019, 1720
  • [24] Effect of resveratrol on scopolamine-induced cognitive impairment in mice
    Rachna Gupta
    Lalit K. Gupta
    Pramod K. Mediratta
    Swapan K. Bhattacharya
    Pharmacological Reports, 2012, 64 (2) : 438 - 444
  • [25] Effect of resveratrol on scopolamine-induced cognitive impairment in mice
    Gupta, Rachna
    Gupta, Lalit K.
    Mediratta, Pramod K.
    Bhattacharya, Swapan K.
    PHARMACOLOGICAL REPORTS, 2012, 64 (02) : 438 - 444
  • [26] Antarctic krill peptides improve scopolamine-induced memory impairment in mice
    Zheng, Jingru
    Gao, Yuanhong
    Ding, Jie
    Sun, Na
    Lin, Songyi
    FOOD BIOSCIENCE, 2022, 49
  • [27] Effect of polyacetylenes on the neurite outgrowth of neuronal culture cells and scopolamine-induced memory impairment in mice
    Yamazaki, M
    Hirakura, K
    Miyaichi, Y
    Imakura, K
    Kita, M
    Chiba, K
    Mohri, T
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2001, 24 (12) : 1434 - 1436
  • [28] Ameliorating effect of spinosin, a C-glycoside flavonoid, on scopolamine-induced memory impairment in mice
    Jung, In Ho
    Lee, Hyung Eun
    Park, Se Jin
    Ahn, Young Je
    Kwon, Guyoung
    Woo, Hyun
    Lee, So Young
    Kim, Ju Sun
    Jo, Yeong-Woo
    Jang, Dae Sik
    Kang, Sam Sik
    Ryu, Jong Hoon
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2014, 120 : 88 - 94
  • [29] Nociceptin orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice
    Hiramatsu, M
    Inoue, K
    BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (03) : 655 - 660
  • [30] Distinct effects of nociceptin analogs on scopolamine-induced memory impairment in mice
    Miwa, Masaya
    Shinki, Chieko
    Uchida, Shogo
    Hiramatsu, Masayuki
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 602 (2-3) : 328 - 333